ATE556079T1 - Verbindungen vom polyphenol-typ zur herrstellung von zusammensetzungen zur prävention oder behandlung von erkrankungen mit abnormaler zellproliferation - Google Patents

Verbindungen vom polyphenol-typ zur herrstellung von zusammensetzungen zur prävention oder behandlung von erkrankungen mit abnormaler zellproliferation

Info

Publication number
ATE556079T1
ATE556079T1 AT06778654T AT06778654T ATE556079T1 AT E556079 T1 ATE556079 T1 AT E556079T1 AT 06778654 T AT06778654 T AT 06778654T AT 06778654 T AT06778654 T AT 06778654T AT E556079 T1 ATE556079 T1 AT E556079T1
Authority
AT
Austria
Prior art keywords
preventing
cell proliferation
treating diseases
abnormal cell
type compounds
Prior art date
Application number
AT06778654T
Other languages
English (en)
Inventor
Gaelle Depierre
Stephane Quideau
Michael Jourdes
Patrick Pardon
Philippe Pourquier
Original Assignee
Fluofarma
Univ Bordeaux 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fluofarma, Univ Bordeaux 1 filed Critical Fluofarma
Application granted granted Critical
Publication of ATE556079T1 publication Critical patent/ATE556079T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT06778654T 2005-07-01 2006-06-23 Verbindungen vom polyphenol-typ zur herrstellung von zusammensetzungen zur prävention oder behandlung von erkrankungen mit abnormaler zellproliferation ATE556079T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507051A FR2887774B1 (fr) 2005-07-01 2005-07-01 Composes de type polyphenols, les compositions les contenant et leur utilisation pour prevenir ou traiter des maladies impliquant une proliferation cellulaire anormale
PCT/FR2006/001455 WO2007003741A2 (fr) 2005-07-01 2006-06-23 Composes de type polyphenols, les compositions les contenant et leur utilisation pour prevenir ou traiter des maladies impliquant une proliferation cellulaire anormale

Publications (1)

Publication Number Publication Date
ATE556079T1 true ATE556079T1 (de) 2012-05-15

Family

ID=36011133

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778654T ATE556079T1 (de) 2005-07-01 2006-06-23 Verbindungen vom polyphenol-typ zur herrstellung von zusammensetzungen zur prävention oder behandlung von erkrankungen mit abnormaler zellproliferation

Country Status (7)

Country Link
US (1) US20090197938A1 (de)
EP (1) EP1901735B1 (de)
AT (1) ATE556079T1 (de)
DK (1) DK1901735T3 (de)
ES (1) ES2389506T3 (de)
FR (1) FR2887774B1 (de)
WO (1) WO2007003741A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5843099A (en) * 1999-09-22 2001-04-24 Baxter International Inc. Cardiac valve and method for preparing a biological tissue
JP4526775B2 (ja) * 2003-03-31 2010-08-18 シーシーアイ株式会社 ヘキサオキシジフェン酸誘導体を有効成分とする抗アレルギー剤

Also Published As

Publication number Publication date
FR2887774A1 (fr) 2007-01-05
EP1901735B1 (de) 2012-05-02
US20090197938A1 (en) 2009-08-06
WO2007003741A2 (fr) 2007-01-11
DK1901735T3 (da) 2012-08-20
EP1901735A2 (de) 2008-03-26
WO2007003741A3 (fr) 2007-03-01
ES2389506T3 (es) 2012-10-26
FR2887774B1 (fr) 2007-08-24

Similar Documents

Publication Publication Date Title
MD3774791T2 (ro) Compuși heterociclici ca imunomodulatori
CR20210415A (es) Compuestos de 3-carbonilamino-5-ciclopentil-1h-pirazol que tienen actividad inhibidoria en cdk2
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
MX2008012479A (es) Tratamiento de enfermedades neurodegenerativas.
GEP20125565B (en) Lactam compounds and their pharmaceutical use
MX2013013692A (es) Halogenoalquil-1,3-oxazinas como inhibidores de beta secretasa 1 (bace1) y/o beta secretasa 2 (bace2).
EA201000563A1 (ru) Триазолпиридиновые ингибиторы 11-бета- гидроксистероид - дегидрогеназы типа i
EA200802390A1 (ru) Конъюгаты аналогов азиридилэпотилона и фармацевтические композиции, содержащие их
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
GEP20125511B (en) Mapk/erk kinase inhibitors
PH12014501334A1 (en) Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
PH12020500134A1 (en) Dihydrooxadiazinones
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
MD3532459T2 (ro) Inhibitori ai LSD1 și utilizările medicale ale acestora
EA201100255A1 (ru) 5-алкинилпиримидины
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
BRPI0517032A (pt) compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades e utilização desses compostos
PH12014502623A1 (en) Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors
MD3355890T2 (ro) Inhibitori de kalikreină plasmatică umană
ATE521609T1 (de) Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs
MX2019012375A (es) Formulaciones del inhibidor del antigeno-1 asociado a la funcion de linfocitos (lfa-1).
TW200728281A (en) Novel N-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
DE602005007471D1 (de) Satraplatin zur behandlung von resistenten oder refrkatären tumoren